Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Abercrombie & Fitch Co. (ANF), American Eagle Outfitters (AEO), Aeropostale, Inc. (ARO): Investing in Apparel Requires a Level Head

Page 1 of 2

The volatility in retailers has been nauseating of late. However, for the deep value investor with a steel stomach, there could be some solid buying opportunities. The major teen retailers have been in a free fall for the past few months, including the likes of Abercrombie & Fitch Co. (NYSE:ANF)American Eagle Outfitters (NYSE:AEO) and Aeropostale, Inc. (NYSE:ARO).

Over the past year, both American Eagle Outfitters (NYSE:AEO) and Aeropostale, Inc. (NYSE:ARO) are down over 30%, yet Abercrombie & Fitch Co. (NYSE:ANF) is relatively flat.

ARO Chart

For now, you can blame the hipsters and value-seeking teenagers who are running to Forever 21 and Urban Outfitters for their clothing needs. This has caused the recent quarter to be abysmal for the three A-retailers.

Same-store sales fell off a cliff for all three, and inventory growth outpaced sales. When inventory growth outpaces sales growth, it’s almost always bad news for retailers. For the second quarter, Aeropostale, Inc. (NYSE:ARO)’s inventory was flat year over year, but sales were down 6%. American Eagle Outfitters (NYSE:AEO) saw inventory levels flat as well, but sales were down 2%. Meanwhile, Abercrombie saw inventory up 2% year over year, but sales were flat.

Earnings told a similar story, all seeing year-over-year declines in EPS. Aeropostale, Inc. (NYSE:ARO) posted a $0.34 loss, whereas it broke even last year. Same-store sales were down 15%. Abercrombie & Fitch Co. (NYSE:ANF) posted second quarter EPS of $0.14, versus $0.20 for the same period last year, while same-store sales were 10% lower. American Eagle Outfitters (NYSE:AEO) had second quarter EPS of $0.10, compared to $0.21 last year, and same-store sales were down 7%.

Never fear
With retail data coming out every month, versus quarterly for the majority of other sectors, overreactions are not uncommon in the apparel business. And when an overreaction happens, you should ask two questions; is management competent? Will the company survive? If the answer is yes and yes, then it’s generally safe to invest.

That’s why I’m excited about the recent pullback in Aeropostale, Inc. (NYSE:ARO). No debt, strong cash position, and it’s generating free cash flow that’s twice its net income. The overreactions at Aeropostale are becoming more and more intense. In the past three years alone, there have been four large sell-offs.


However, the following surge in the stock is becoming more and more intense. During the latest pullback in 2011, the stock bottomed out around $9.60, and then the stock soared more than 100% over the next six months.


Over the past decade, Aeropostale has offered investors solid returns. Sure, it has missed a season, but this has historically proven to be a great time to buy. From 2004 and up to 2012, Aeropostale, Inc. (NYSE:ARO) enjoyed returns on invested capital between35% and 60%. Up until the the recent pullback, Aeropostle had outperformed its major peers over the last eight years.

ARO Chart

Sales at Aeropostale are still robust, generating revenue at decade highs of close to $2.4 billion over the trailing 12 months. The recent issue is related to margin pressure. Cost-cutting and more aggressive overhead management should get margins back in line for next season.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!